News

November 28, 2016

Increasing TIP60 Levels May Halt Tumor Growth and Metastasis, Study Suggests

News

Controlling the expression levels of a protein called TIP60, whose activity suppresses tumor growth and metastasis, may become a potential therapeutic strategy to treat several cancer types, including cervical cancer, ... Read more

November 23, 2016

CEL-SCI Asks FDA to Lift Partial Clinical Hold on Multikine for Head and Neck Cancers

News

CEL-SCI’s Phase 3 clinical trial assessing its investigational drug Multikine in patients with squamous cell carcinoma of the head and neck (SCCHN) recently was placed on partial clinical hold by ... Read more

November 21, 2016

Urine Test May Soon Be Able to Predict Likelihood of Cervical Cancer

News

Researchers at Johns Hopkins Medicine have developed a new, highly accurate urine test that can predict whether a woman is likely to develop cervical cancer. The test examines epigenetic changes ... Read more

November 18, 2016

Genexine, Merck Collaborate to Assess Therapy Combo in HPV-induced Cervical Cancer

News

Genexine and Merck (MSD) are collaborating to evaluate Genexine’s HPV DNA vaccine GX-188E in combination with Keytruda (pembrolizumab) as a potential treatment for patients with HPV-induced cancers. Under the terms of the agreement, Genexine ... Read more

November 16, 2016

Group Health System Clarifies New HPV Vaccine Protocol

News

Group Health, a healthcare system in Washington state, is preparing to explain and administer to patients the new human papilloma virus (HPV) vaccination protocol, which lowers barriers to life-saving medication by ... Read more

November 14, 2016

Early Trial Data of Axal Combo Therapy for HPV-linked Cervical Cancer Presented by Advaxis

News

Advaxis recently presented new data demonstrating the clinical benefit of Axal, its lead immunotherapy candidate, both as a single therapy and in combination with other immunotherapies, for patients with HPV-associated cervical cancer. ... Read more

November 11, 2016

New e-Book Shows Inconsistent Insurance Policies for Cancer Screening

News

According to a new review by the Prevent Cancer Foundation, insurance policies covering screening methods for five types of cancer show significant inconsistencies across healthcare plans, even though cancer screening is ... Read more

November 9, 2016

Advaxis Begins Phase 3 Study of AXAL for Advanced Cervical Cancer

News

Advaxis has begun its Phase 3 clinical trial evaluating axalimogene filolisbac, or AXAL, administered in the adjuvant setting following chemotherapy and radiation in women with high-risk, locally advanced cervical cancer. ... Read more

November 7, 2016

Inadequate Cervical Cancer Prevention Causes Thousands of Unnecessary Deaths

News

A series of articles highlights that a vast majority of deaths in cervical cancer occur in low- and middle-income countries, despite the fact that prevention measures would cost little in comparison with ... Read more

November 4, 2016

To Combat Cervical Cancer, Guidelines Urge HPV Screening at All Healthcare Economic Levels

News

The American Society of Clinical Oncology (ASCO) has published clinical practice guidelines for the secondary prevention of cervical cancer, recommending testing for human papillomavirus (HPV) DNA in healthcare systems at ... Read more